Royal Palms Capital’s Ambev ABEV Stock Holding History

Royal Palms Capital’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,726	Closed	-$29K	–	51
2025 Q4	$29K	Buy	+11,726	New	+$27.9K	0.03%	34

Other funds holding ABEV

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCP

Seafarer Capital Partners Larkspur, California $434M AUM 22.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Royal Palms Capital's ABEV Position: Q1 2026 in Review

Royal Palms Capital sold out of Ambev (ABEV) in Q1 2026, closing a stake of 11,726 shares — an estimated $29K sold.

Royal Palms Capital first reported a position in ABEV in Q4 2025 and held it in 1 quarter. The position peaked at $29K in Q4 2025. 404 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

Royal Palms Capital reported no remaining Ambev position as of Q1 2026 after selling out during the quarter.
Royal Palms Capital sold 11,726 Ambev shares in Q1 2026, an estimated $29K.
Royal Palms Capital first reported a position in Ambev in Q4 2025 and held it in 1 quarter.
Royal Palms Capital's Ambev position peaked at $29K in Q4 2025.
404 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Royal Palms Capital's 13F filing for Q1 2026, filed 7 May 2026.